Excess RNA Can Directly Drain Cellular Energy During Poxvirus Infection
A cell can tolerate a great deal of molecular traffic, but too much RNA appears to push one of its most essential systems past the breaking point. Researchers at Texas A&M College of Veterinary Medicine and Biomedical Sciences found that excess RNA produced during poxvirus infection can damage mitochondria, the organelles that generate most of a cell’s usable energy.
The work, published in Proceedings of the National Academy of Sciences, adds a new layer to the biology of RNA control. RNA has long been recognized as a carrier of genetic instructions and a trigger for immune surveillance, especially when viral infection floods cells with unusual RNA species. This study shows that the consequences are broader than immune activation alone: RNA overload can impair mitochondrial respiration directly, leaving cells less able to produce ATP, the energy currency required for survival and normal function.
One sentence captures the biological surprise. Excess RNA can injure mitochondria even before the immune system fully engages.
That matters because mitochondria are not passive energy factories. They depend on a tightly maintained electrical gradient across their inner membranes to drive ATP synthesis, and even small disturbances in that gradient can reduce energy output. The researchers propose that RNA’s negative charge may interfere with this delicate balance when too much of the molecule accumulates near mitochondria. The exact biochemical sequence is still unresolved, but the direction of injury is now much clearer: RNA accumulation itself can be toxic to cellular energetics.
Mitochondrial Injury Appeared Before Immune Activation
The most important mechanistic finding came from experiments that separated mitochondrial damage from the immune response usually associated with viral RNA. Investigators initially suspected that excess RNA was harming mitochondria indirectly by provoking antiviral signaling pathways. Instead, when isolated mitochondria were exposed to RNA, injury still occurred. The damage did not depend on the classic immune pathways normally activated during infection.
Dr. Zhilong Yang, a professor in the Department of Veterinary Pathobiology, framed RNA degradation as more than a housekeeping process. Cells break down RNA to regulate protein production and eliminate faulty transcripts, but the new findings show that this cleanup system also appears to preserve energy homeostasis. When RNA is not cleared efficiently, the buildup can overwhelm the cell’s ability to protect mitochondria.
The study also distinguishes between different RNA species. Double-stranded RNA has already been known to provoke immune alarms during infection. The new result is more unsettling because it extends the danger to ordinary messenger RNA, the same molecule cells use every day to direct protein synthesis. In other words, a molecule central to normal biology becomes harmful when too much of it accumulates.
Poxviruses, which include the agents responsible for smallpox and mpox, face a paradox in this environment. They rely entirely on host cells for replication, yet excessive viral RNA can damage the host machinery the virus needs to keep reproducing. The findings suggest that these viruses must actively balance RNA levels to keep infected cells functional long enough to support viral propagation. If the host cell becomes too energetically compromised, the virus loses the platform it needs.
RNA Homeostasis May Matter Beyond Viral Disease
Although the experiments centered on poxvirus infection, the implications extend well past virology. Abnormal RNA accumulation has been observed in a range of conditions, including certain cancers, neurodegenerative diseases, and disorders linked to aging. Mitochondrial dysfunction already sits near the center of those illnesses, so a mechanism that directly links RNA buildup to impaired respiration could help explain why cells fail in such diverse settings.
The translational interest is clear, but the data still stop short of proving disease causation in people. The study does not establish that RNA buildup drives aging-related disorders or neurodegeneration in humans, nor does it show that existing mRNA vaccines damage mitochondria in clinical use. What it does provide is a mechanistic framework for thinking about how large RNA loads are handled inside cells and what happens when degradation systems cannot keep pace.
For RNA-based medicines, the finding is especially relevant. mRNA vaccines and other RNA therapeutics depend on introducing RNA into cells so that proteins can be made efficiently. Understanding how cells sense, process, and clear that RNA is essential for designing therapies that are both effective and biologically tolerable. If excessive RNA can stress mitochondria under some circumstances, then RNA dose, stability, and degradation kinetics deserve close attention in future platform design.
The bedside consequence is indirect but real. As RNA therapies expand, the field will need to understand not only how long RNA persists and how much protein it produces, but also how the cell’s energy machinery responds to the load.
Dr. Djamal Brahim Belhaouari, the study’s first author, described the work as evidence of a previously unknown cellular response to RNA. That framing is justified by the experimental sequence: RNA buildup, mitochondrial dysfunction, then immune activation in some settings, rather than immune activation alone explaining the injury. The order of events suggests a distinct toxic pathway that may operate in parallel with antiviral defense.
Further work will need to identify the precise molecular interaction between RNA and mitochondria, determine whether the effect is generalizable across cell types, and establish how much RNA accumulation is required before energy production begins to fail. Those answers will decide how broadly the mechanism applies in infection, aging, and RNA medicine. For now, the central finding is stark: when RNA accumulates beyond normal limits, even a molecule cells depend on every day can become a direct threat to mitochondrial function.